- Home
- GP vs CDIO Comparison
GP vs CDIO Comparison
Compare GP & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GP | CDIO |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Canada | United States |
| Employees | N/A | 9 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.1M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | GP | CDIO |
|---|---|---|
| Price | $1.02 | $1.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.6K | ★ 1.3M |
| Earning Date | 02-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $171,906.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.18 |
| 52 Week High | $4.00 | $7.91 |
Technical Indicators
Market Signals| Indicator | GP | CDIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 36.00 |
| Support Level | $0.87 | $1.64 |
| Resistance Level | $1.07 | $2.03 |
| Average True Range (ATR) | 0.07 | 0.47 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 36.84 | 1.81 |
Price Performance
Historical ComparisonAbout GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About CDIO Cardio Diagnostics Holdings Inc.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.